{"cik":2029039,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"NASUS PHARMA LTD.","units":{"USD":[{"end":"2024-12-31","val":3929000,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29"},{"end":"2024-12-31","val":3929000,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2024Q4I"},{"end":"2025-06-30","val":4953000,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29","frame":"CY2025Q2I"},{"end":"2025-12-31","val":2163000,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2025Q4I"}]}}